<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48640">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01970228</url>
  </required_header>
  <id_info>
    <org_study_id>T125/2012</org_study_id>
    <secondary_id>EVO13086</secondary_id>
    <nct_id>NCT01970228</nct_id>
  </id_info>
  <brief_title>Imaging of Joint Replacement Complications by PET/CT</brief_title>
  <acronym>Propeli</acronym>
  <official_title>Prospective Intra-individual Comparison of 18F-FDG and 68Ga-citrate PET/CT in Symptomatic Total Hip Arthroplasty Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Turku PET Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <authority>Finland: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total hip replacement is the well-established surgical method for treatment of hip
      osteoarthritis and related diseases. The outcome of the procedure is commonly satisfactory
      and most patients will not need any revision surgery. However, the procedure has its
      complications, including (1) periprosthetic infection, (2) mechanical loosening caused by
      wear particles and (3) allergic reaction caused by metal ions released from metal-on-metal
      bearing surfaces. The unsolved clinical problem is related to the differential diagnosis of
      these conditions. The purpose of this prospective clinical study is to compare the efficacy
      of two techniques of PET/CT imaging in the differential diagnosis of these complications.
      The PET imaging, performed during a single day, will include the head-to-head comparison of
      18FDG PET/CT and 68Ga-citrate PET/CT imaging.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Detection of deep low-grade infection</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Adverse Reactions to Metal Debris</condition>
  <condition>Infection of Total Hip Joint Prosthesis</condition>
  <condition>Mechanical Loosening of Prosthetic Joint</condition>
  <arm_group>
    <arm_group_label>Adverse reaction to metal debris</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Adverse tissue reactions to metal debris in patients with metal-on-metal bearings of the hip prosthesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-grade periprosthetic joint infection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low-grade periprosthetic joint infection in patients with cementless total hip replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mechanical loosening</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mechanical loosening of cementless total hip prosthesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>68Ga  PET/CT imaging</intervention_name>
    <description>Single-day study of the two PET tracers</description>
    <arm_group_label>Adverse reaction to metal debris</arm_group_label>
    <arm_group_label>Low-grade periprosthetic joint infection</arm_group_label>
    <arm_group_label>Mechanical loosening</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>18F-FDG PET/CT imaging</intervention_name>
    <arm_group_label>Adverse reaction to metal debris</arm_group_label>
    <arm_group_label>Low-grade periprosthetic joint infection</arm_group_label>
    <arm_group_label>Mechanical loosening</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (age more than 17 years) patients with uncemented total hip replacement

          -  American Society of Anesthesiology score I-III

          -  Local symptoms and/or radiographic findings of the operated hip suggesting mechanical
             loosening, low-grade infection or inflammation related to metal-on-metal bearings of
             the hip prosthesis

        Exclusion Criteria:

          -  any related condition of the index hip (such as severe infection or periprosthetic
             fracture) which is a contraindication for diagnostic PET imaging studies and requires
             an immediate surgical intervention

          -  any systemic disorder or condition (ASA IV) which makes the patient an unlikely
             candidate for revision surgery.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hannu T Aro, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hannu T Aro, MD, PhD</last_name>
    <phone>+358-40-3537644</phone>
    <email>hannu.aro@utu.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannu T Aro, MD, PhD</last_name>
      <phone>+358-40-3537644</phone>
      <email>hannu.aro@utu.fi</email>
    </contact>
    <investigator>
      <last_name>Marko Seppänen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Lankinen P, Lehtimäki K, Hakanen AJ, Roivainen A, Aro HT. A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. EJNMMI Res. 2012 Jul 23;2(1):41. doi: 10.1186/2191-219X-2-41.</citation>
    <PMID>22824200</PMID>
  </reference>
  <reference>
    <citation>Lankinen P, Mäkinen TJ, Pöyhönen TA, Virsu P, Salomäki S, Hakanen AJ, Jalkanen S, Aro HT, Roivainen A. (68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):352-64. Epub 2007 Nov 24.</citation>
    <PMID>18038133</PMID>
  </reference>
  <reference>
    <citation>Mäkinen TJ, Lankinen P, Pöyhönen T, Jalava J, Aro HT, Roivainen A. Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus. Eur J Nucl Med Mol Imaging. 2005 Nov;32(11):1259-68. Epub 2005 Jul 9.</citation>
    <PMID>16007423</PMID>
  </reference>
  <reference>
    <citation>Koort JK, Mäkinen TJ, Knuuti J, Jalava J, Aro HT. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med. 2004 Aug;45(8):1406-11.</citation>
    <PMID>15299068</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 22, 2013</lastchanged_date>
  <firstreceived_date>September 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
